Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.
about
If you build it, they will come: unintended future uses of organised health data collectionsFeedback of Individual Genetic Results to Research Participants: Is It Feasible in Europe?Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom.Outdated risk assessment in a family with Duchenne dystrophy: Implications for duty to reassessRecontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom.Expect the unexpected: screening for secondary findings in clinical genomics research.Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing.Recontacting in clinical practice: the views and expectations of patients in the United Kingdom.Reassessing carrier status for dystrophinopathies.Genomic medicine for kidney disease.Physicians' duty to recontact and update genetic advice.Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.Recontacting in clinical genetics and genomic medicine? We need to talk about it.Reinterpretation of sequence variants: one diagnostic laboratory's experience, and the need for standard guidelines.Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study.Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines
P2860
Q27007763-E334C7E8-75B8-41F7-BF59-BA15D63B02A4Q28601041-EC0A7FE4-E3EE-41CC-B1B5-442ADBD13F7AQ37314408-FA176FA2-C9D2-40D3-A5C2-42C71A6A525CQ37316166-9038EC13-1FE9-4225-B5DC-3D3838C99179Q37650365-3EE514AB-E3E3-473C-AB6A-DDE9BCC7102CQ38731962-86A05746-24D7-41F7-A65F-23635DDAE4BDQ38866800-BA843E70-528F-4266-A070-08A43061BC16Q41640975-4D650759-8F34-490F-91B7-5804F4E82AD1Q42386733-30C3794C-EC8A-4113-A786-28390901B892Q47200436-4FB6AD45-8F25-4CEC-BB62-CFD26988EAEEQ47439032-D3DA2937-0C22-4EB3-B372-F3F3B5E5666FQ47547338-A748983F-EDD9-4A8B-8361-E53A7594AEB0Q48263654-3C1CFE2B-51A5-43F8-AC2C-3F4CEA6F6AAEQ49841757-0F42D032-E7A4-4827-8272-87C92C1BBAE4Q50025441-69D8A608-BB95-435F-94CA-056346FF3B59Q52571633-5002AD15-8C87-4C4B-B088-7AB14D86EF7BQ57640049-C45684DC-C85F-4814-A730-C65CD94ACB2B
P2860
Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Is there a duty to recontact i ...... atic review of the literature.
@en
type
label
Is there a duty to recontact i ...... atic review of the literature.
@en
prefLabel
Is there a duty to recontact i ...... atic review of the literature.
@en
P2093
P2860
P356
P1433
P1476
Is there a duty to recontact i ...... matic review of the literature
@en
P2093
Adelita V Ranchor
Anneke M Lucassen
Ellen Otten
Erwin Birnie
Irene M Van Langen
Mirjam Plantinga
P2860
P2888
P304
P356
10.1038/GIM.2014.173
P407
P577
2014-12-11T00:00:00Z